Cargando…

SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance

Detalles Bibliográficos
Autores principales:	Sgherza, Nicola, Di Gennaro, Daniela, Curci, Paola, Rizzi, Rita, Roccotelli, Daniela, Croce, Maria, Avantaggiato, Martina, Ruga, Loredana, Strafella, Vanda, Vitucci, Angelantonio, Palma, Antonio, Russo Rossi, Antonella V., Troiano, Teresa, Larocca, Angela M. V., Chironna, Maria, Tafuri, Silvio, Albano, Francesco, Musto, Pellegrino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649266/ https://www.ncbi.nlm.nih.gov/pubmed/36382051 http://dx.doi.org/10.1097/HS9.0000000000000800

Ejemplares similares

COVID-19 in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): An Observational Retrospective Study
por: Sgherza, Nicola, et al.
Publicado: (2021)

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
por: Sgherza, N., et al.
Publicado: (2022)

P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
por: Sgherza, N, et al.
Publicado: (2022)

Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study
por: Sgherza, Nicola, et al.
Publicado: (2021)

Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Sgherza, Nicola, et al.
Publicado: (2023)

Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients
por: Sgherza, Nicola, et al.
Publicado: (2022)

P-159: Effectiveness of anti-SARS-CoV-2 vaccine “booster” dose in patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2022)

Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia
por: Sgherza, Nicola, et al.
Publicado: (2022)

“Hemolysis, or not Hemolysis, that is the Question”. Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency
por: Sgherza, Nicola, et al.
Publicado: (2020)

What Is New in the Treatment of Smoldering Multiple Myeloma?
por: Bolli, Niccolo’, et al.
Publicado: (2021)

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

Immunophenotypic studies of monoclonal gammopathy of undetermined significance
por: Olteanu, Horatiu, et al.
Publicado: (2008)

Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
por: Aslam, Nabeel, et al.
Publicado: (2021)

Serological Response to BNT162b2 Anti-Sars-Cov-2 mRNA Vaccine in Patients with Transfusion Dependent Thalassemia
por: Zucano, Stefania, et al.
Publicado: (2021)

Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
por: Steiner, Normann, et al.
Publicado: (2016)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
por: Sigurbergsdóttir, Aðalbjörg Ýr, et al.
Publicado: (2022)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
por: Lyle, Melissa A., et al.
Publicado: (2022)

Hypereosinophilia with a pinch of salt and pepper
por: Vitucci, Angelantonio, et al.
Publicado: (2021)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
por: Sgherza, Nicola, et al.
Publicado: (2021)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
por: Hartley, M.A., et al.
Publicado: (2010)

Aspergillus fumigatus Scleritis Associated with Monoclonal Gammopathy of Undetermined Significance
por: Jo, Dong Hyun, et al.
Publicado: (2010)

Advances in the understanding of IgM monoclonal gammopathy of undetermined significance
por: Paludo, Jonas, et al.
Publicado: (2017)

Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis
por: Gámez, Beatriz, et al.
Publicado: (2018)

Necrotising fasciitis in a patient with monoclonal gammopathy of undetermined significance
por: Vella, John X., et al.
Publicado: (2019)

The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients
por: Gagnon, Marie-France, et al.
Publicado: (2019)

Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS)
por: Zushi, Yuriko, et al.
Publicado: (2019)

Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021)

Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?
por: Kapoor, Prashant, et al.
Publicado: (2022)

Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
por: Piccolomo, Antonio, et al.
Publicado: (2020)

A Case of Cardiac Dysfunction Associated with Monoclonal Gammopathy of Undetermined Significance
por: Jang, Suk-Tae, et al.
Publicado: (2009)

A Case of Crystalline Keratopathy in Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Koo, Hyun, et al.
Publicado: (2011)

Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016)

Monoclonal gammopathy of undetermined significance: a contraindication for living kidney donation?
por: Serra, Nuria, et al.
Publicado: (2011)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
por: Lomas, Oliver C., et al.
Publicado: (2020)

Intraosseous schwannoma of the femur in a patient with monoclonal gammopathy of undetermined significance
por: McAleese, Timothy, et al.
Publicado: (2020)

THE ROLE OF A MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE DIAGNOSIS IN HEALTHCARE UTILIZATION
por: Castaneda-Avila, Maira, et al.
Publicado: (2022)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
por: Tanenbaum, Hilary C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m994g5lomjtdturf4es76tptfk